ConductScience.org, home

Trial · NCT00320190

Participant flow12

How many started, completed or left each group, period by period.

PeriodMilestoneGroupParticipantsUnits counted
First 12 MonthsSTARTEDDasatinib, 100 mg19
First 12 MonthsSTARTEDImatinib, 800 mg13
First 12 MonthsCOMPLETEDDasatinib, 100 mg11
First 12 MonthsCOMPLETEDImatinib, 800 mg3
First 12 MonthsNOT COMPLETEDDasatinib, 100 mg8
First 12 MonthsNOT COMPLETEDImatinib, 800 mg10
Long-term (12-month) ExtensionSTARTEDDasatinib, 100 mg11
Long-term (12-month) ExtensionSTARTEDImatinib, 800 mg3
Long-term (12-month) ExtensionCOMPLETEDDasatinib, 100 mg2
Long-term (12-month) ExtensionCOMPLETEDImatinib, 800 mg1
Long-term (12-month) ExtensionNOT COMPLETEDDasatinib, 100 mg9
Long-term (12-month) ExtensionNOT COMPLETEDImatinib, 800 mg2

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00320190/flow